During the past decade, Institute of Oncology Research conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Institute of Oncology Research" #1 collaborator was "Arcispedale Santa Maria Nuova-IRCCS" with 1 trials as a collaborator, "Azienda Ospedaliero Universitaria Maggiore della Carita" with 1 trials as a collaborator and "Institute of Pathology, Locarno, Ticino, Switzerland" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Institute of Oncology Research" are "Follicular Lymphoma" (1 trials) and "Mature B-Cell Neoplasm" (1 trials). Many other conditions were trialed in "Institute of Oncology Research" in a lesser frequency.

Most popular intervention types in "Institute of Oncology Research" are "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Liquid Biopsy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Institute of Oncology Research" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Institute of Oncology Research". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Institute of Oncology Research, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Institute of Oncology Research, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".